Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line
Background: targeted cancer nanotherapy represents a golden goal for nanobiotechnology to overcome the severe side effects of conventional chemotherapy. Hybrid nanoliposomes (HLs) composed of L-α-dimyristoylphosphatidylcholine (DMPC) and Polyoxyethylene (23) dodecyl ether (C12 (EO)23 ) can integrate...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2016-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/399 |